Seeing Eye to Eye on the Management of Neurotrophic Keratitis (Online CME Monograph)
Activity Description and Purpose
Neurotrophic keratitis (NK) evolves from damage to the sensory fibers of the trigeminal nerve, the ophthalmic branch of which innervates the cornea. Assessment of corneal sensation is fundamental to diagnosis, and early diagnosis is crucial to management because untreated NK can result in loss of vision. This educational activity features real-world cases of patients with various stages of NK and aims to provide ophthalmologists with clinical data and pearls to aid in the diagnosis and treatment of NK. The desired results of this educational activity are to familiarize ophthalmologists with real-world examples of diagnosing and effectively and safely treating patients with all stages of NK that can be applied to their own practice.
Target Audience
This educational activity is intended for ophthalmologists.
Learning Objectives
After completing this activity, participants will be better able to:
- Integrate corneal sensation assessments to cases that raise clinical suspicion of neurotrophic keratitis
- Apply clinical evidence to treatment selection for patients diagnosed with any stage of neurotrophic keratitis
Faculty
Stephen C. Pflugfelder, MD (Chair) | |
Kourtney H. Houser, MD
| |
Sumitra Khandelwal, MD |
Disclosure Policy
MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.
Faculty
Kourtney H. Houser, MD, is a consultant for Allergan, Bausch & Lomb Incorporated, Carl Zeiss Meditec, Inc, Dompé US, Inc, Sight Sciences, and Trukera; and is an advisory board member of Orasis Pharmaceuticals and Rayner.
Sumitra Khandelwal, MD, is a consultant for Allergan, Bausch & Lomb Incorporated, and Dompé US, Inc.
Stephen C. Pflugfelder, MD, is a consultant for Alcon, Dompé US, Inc, HanAll Biopharma, Kala Pharmaceuticals, KOWA Pharmaceuticals America, Inc, and Nicox; and is a contracted researcher for Dompé US, Inc.
Peer Reviewer
This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.
Planners, Managers, and Writers
MedEdicus planners, managers, and writers have no relevant commercial relationships to disclose.
Accreditation Statement
MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
MedEdicus LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Commercial Support
This continuing medical education activity is supported through an educational grant from Dompé US, Inc.
Off-Label Discussion
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.
Provider Contact Information
For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC or Dompé US, Inc.
This CME activity is copyrighted to MedEdicus LLC ©2024. All rights reserved. MedEdicus does not claim copyright to material included herein owned by third parties for which attribution or citation has been made. 307b
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Participation